Invasive candidiasis is an important health-care-associated fungal infection that can be
caused by several Candida spp.; the most common species is Candida albicans, but the …

Candida species, belonging to commensal microbial communities in humans, cause
opportunistic infections in individuals with impaired immunity. Pathogens encountered in …

The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Despite advances in antifungal therapy, the mortality associated with invasive candidiasis
remains as high as 40%. This review summarizes recent trends and current strategies …

Cultures are negative in∼ 50% of invasive candidiasis. Data are emerging for the
performance of nonculture tests such as mannan/antimannan, Candida albicans germ tube …

Fungal infections, such as candidiasis caused by Candida, pose a problem of growing
medical concern. In developed countries, the incidence of Candida infections is increasing …

Background: Fungal infections are of increasing incidence and importance in
immunocompromised and immunocompetent patients. Timely diagnosis relies on …

Invasive fungal diseases (IFDs) present an increasing global burden in
immunocompromised and other seriously ill populations, including those caused by …

Invasive candidiasis (IC) is the most frequent health care associated invasive fungal
infection. It is also associated with high morbidity, mortality, and cost. The most frequent …

The treatment of invasive candidiasis has changed greatly in the past decade and must
continue to evolve if we are to improve outcomes in this serious infection. A review of recent …